MedTrace Logo

Malignant Obstruction ZILVER Against Routine Therapy (MOZART I)

NCT00196105 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 241

Last updated 2011-10-03

Study results available
· View outcomes & findings →

Summary

This study compares the 6 mm nitinol Zilver biliary endoprostheses and the 10 mm nitinol Zilver biliary endoprostheses to the 10 mm Wallstent in appropriate patients in need of palliative treatment of malignant obstructive jaundice.

Conditions

  • Biliary Tract Neoplasms
  • Pancreatic Neoplasms
  • Jaundice, Obstructive

Interventions

DEVICE

6 mm Nitinol Zilver Stent

DEVICE

10 mm Nitinol Zilver Stent

DEVICE

10 mm Stainless Steel Wallstent

Sponsors & Collaborators

  • Cook Group Incorporated

    lead INDUSTRY

Principal Investigators

  • Douglas Howell, M.D. · MaineHealth

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-09-30
Primary Completion
2006-12-31
Completion
2006-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00196105 on ClinicalTrials.gov